Raymond James Maintains Outperform on TriCo, Raises Price Target to $48
Raymond James maintains TriCo (NASDAQ:TCBK) with a Outperform and raises the price target from $44 to $48.
Wells Fargo Maintains Overweight on Ollie’s Bargain Outlet, Raises Price Target to $75
Wells Fargo analyst Edward Kelly maintains Ollie's Bargain Outlet (NASDAQ:OLLI) with a Overweight and raises the price target from $70 to $75.
Raymond James Downgrades Preferred Bank to Market Perform
Raymond James analyst David Feaster downgrades Preferred Bank (NASDAQ:PFBC) from Outperform to Market Perform.
Wells Fargo Maintains Equal-Weight on PVH, Lowers Price Target to $70
Wells Fargo analyst Ike Boruchow maintains PVH (NYSE:PVH) with a Equal-Weight and lowers the price target from $80 to $70.
Wells Fargo Maintains Overweight on Hanesbrands, Lowers Price Target to $13
Wells Fargo analyst Ike Boruchow maintains Hanesbrands (NYSE:HBI) with a Overweight and lowers the price target from $18 to $13.
Wells Fargo Maintains Overweight on Capri Holdings, Lowers Price Target to $70
Wells Fargo analyst Ike Boruchow maintains Capri Holdings (NYSE:CPRI) with a Overweight and lowers the price target from $85 to $70.
Scotiabank Downgrades Canadian National Railway to Sector Perform, Lowers Price Target to C$150
Scotiabank analyst Konark Gupta downgrades Canadian National Railway (TSX:CNR) from Sector Outperform to Sector Perform and lowers the price target from C$172 to C$150.
Sorrento’s Scilex Holding Company To Acquire Ancora Medical; Terms Not Disclosed
Ancora Medical Inc. ("Ancora") is a privately held medical technology company with an FDA approved product in February 2020, the Nerve Block Catheter Set which is indicated for surgical pain management during